Docetaxel and niclosamide-loaded nanofiber systems for improved chemo-therapeutic activity and resistance reversal in prostate cancer
From superior activity of DTX-NIC NF and re-sensitization of resistant cells, we conclude that DTX-NIC NF could be a beneficial therapeutic regimen in preventing tumor recurrence in PCa.
Authors
- Dharmendra Kumar Khatri (ORCID: https://orcid.org/0000-0001-7066-7706)
- Dilip Kumar Arya (ORCID: https://orcid.org/0000-0002-4087-3311)
- Saurabh Shah (ORCID: https://orcid.org/0000-0002-0538-9030)
- Shubham Kanaujiya (ORCID: https://orcid.org/0009-0001-0277-2130)
- Giriraj Pandey
- Saurabh Srivastava (ORCID: https://orcid.org/0000-0001-6420-1440)
- Amit Asthana (ORCID: https://orcid.org/0000-0002-3419-884X)
- Sachin Chandankar
- P.S. Rajinikanth (ORCID: https://orcid.org/0000-0002-1000-4211)
- Paras Famta
- Akshay Shinde
- Abhishek Sharma (ORCID: https://orcid.org/0000-0002-8925-305X)
- Anamika Sharma (ORCID: https://orcid.org/0009-0001-7537-4627)
- Rahul Kumar (ORCID: https://orcid.org/0000-0002-2419-2428)
- Gurpreet Singh (ORCID: https://orcid.org/0000-0002-1375-3189)
- Swapnil Shinde
- Ganesh Vambhurkar
- Sajja Bhanu Prasad
- Suraj Wagh
Institutions
- Babasaheb Bhimrao Ambedkar University (IN)
- NIMS University (IN)
- National Institute of Pharmaceutical Education and Research - Ahmedabad (IN)
- National Institute of Pharmaceutical Education and Research (IN)
- The Medical Device (United Kingdom) (GB)
- National Institute of Pharmaceutical Education and Research (IN)
Publication Details
- Journal
- Drug Development and Industrial Pharmacy
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1080/03639045.2025.2453533
- Citations
- 18
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 10.75